THE PRESENT INVENTION RELATES TO A SOLID ORAL DOSAGE FORM COMPRISING A THERAPEUTICALLY EFFECTIVE AMOUNT OF ALISKIREN OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND WHEREIN THE ACTIVE INGREDIENT IS PRESENT IN AN AMOUNT OF MORE THAN 46% BY WEIGHT BASED ON THE TOTAL WEIGHT OF THE ORAL DOSAGE FORM.